Innovators in vaginal drug delivery
“This device will be unbelievably popular with miscarriage patients as pessary leakage is the most frequent complaint, causing significant anxiety. The benefits of reducing psychological trauma, anxiety and depression are badly needed.”
New official UK medical guidance* recommends vaginal progesterone to reduce miscarriages
“Thanks to NICE’s new miscarriage management guidance, for the first time we now have a recommended medication to prescribe to help reduce the incidence of miscarriages: vaginal micronised progesterone. This new device addresses patients’ issues of leakage and inconvenience previously associated with vaginally-delivered progesterone.”
“This novel platform is of great benefit to anyone using a vaginally-delivered medication. By addressing the major issue of leakage, women can be assured the device delivers the correct dose in a convenient, tidy and less invasive fashion. It is truly a transformative device.”
“The new guidance, from the health watchdog NICE, is based on research suggesting the treatment could lead to 8,450 more births each year in the UK. The more miscarriages a woman had, the more effective progesterone was, the trial found.”
